STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Hyperfine, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Hyperfine, Inc. (HYPR) Chief Operating Officer reported a small insider sale of Class A common stock. On 11/19/2025, the officer sold 1,405 shares at a price of $1.08 per share. After this transaction, the officer beneficially owns 379,657 shares of Hyperfine Class A common stock in direct ownership form.

The company states that the sale was made to cover tax withholding obligations triggered by the vesting of restricted stock units granted on March 28, 2022 and April 28, 2022 under a “sell to cover” provision in the RSU agreement. This means the shares were sold automatically to pay taxes due when the RSUs vested, rather than as a discretionary open-market sale.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
TEISSEYRE THOMAS

(Last) (First) (Middle)
C/O HYPERFINE, INC.
351 NEW WHITFIELD STREET

(Street)
GUILFORD CT 06437

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hyperfine, Inc. [ HYPR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 11/19/2025 S 1,405 D $1.08(1) 379,657 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.
/s/ Brett Hale, Attorney-in-Fact 11/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Hyperfine (HYPR) disclose in this Form 4 filing?

The filing shows that the Chief Operating Officer of Hyperfine, Inc. (HYPR) sold 1,405 shares of Class A common stock on 11/19/2025 at $1.08 per share and now holds 379,657 shares directly.

Why did the Hyperfine COO sell 1,405 shares of HYPR stock?

The company explains that the sales were made to cover tax withholding obligations related to the vesting of restricted stock units granted on March 28, 2022 and April 28, 2022 under a “sell to cover” provision.

How many Hyperfine (HYPR) shares does the reporting person still own after the transaction?

Following the reported sale, the Chief Operating Officer beneficially owns 379,657 shares of Hyperfine Class A common stock in direct ownership.

What type of security did the Hyperfine officer sell in this Form 4?

The transaction involved Class A common stock of Hyperfine, Inc. (HYPR), reported as a disposition coded as a sale at a price of $1.08 per share.

Was this Hyperfine Form 4 filed for one reporting person or a group?

The document states that it is a Form filed by one reporting person, specifically the company’s Chief Operating Officer.

Does this Hyperfine Form 4 involve any derivative securities or options?

The section for derivative securities is included but contains no reported transactions, while the explanation notes sales tied to the vesting of restricted stock units (RSUs).

HYPERFINE

NASDAQ:HYPR

HYPR Rankings

HYPR Latest News

HYPR Latest SEC Filings

HYPR Stock Data

103.97M
78.17M
6.67%
14.46%
2.6%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
GUILFORD